229 related articles for article (PubMed ID: 20373479)
1. Pregabalin in outpatient detoxification of subjects with mild-to-moderate alcohol withdrawal syndrome.
Di Nicola M; Martinotti G; Tedeschi D; Frustaci A; Mazza M; Sarchiapone M; Pozzi G; Bria P; Janiri L
Hum Psychopharmacol; 2010 Apr; 25(3):268-75. PubMed ID: 20373479
[TBL] [Abstract][Full Text] [Related]
2. Pregabalin, tiapride and lorazepam in alcohol withdrawal syndrome: a multi-centre, randomized, single-blind comparison trial.
Martinotti G; di Nicola M; Frustaci A; Romanelli R; Tedeschi D; Guglielmo R; Guerriero L; Bruschi A; De Filippis R; Pozzi G; Di Giannantonio M; Bria P; Janiri L
Addiction; 2010 Feb; 105(2):288-99. PubMed ID: 20078487
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of pregabalin in alcohol dependence.
Martinotti G; Di Nicola M; Tedeschi D; Mazza M; Janiri L; Bria P
Adv Ther; 2008 Jun; 25(6):608-18. PubMed ID: 18553183
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of pregabalin in the treatment of alcohol withdrawal syndrome: a randomized placebo-controlled trial.
Förg A; Hein J; Volkmar K; Winter M; Richter C; Heinz A; Müller CA
Alcohol Alcohol; 2012; 47(2):149-55. PubMed ID: 22215002
[TBL] [Abstract][Full Text] [Related]
5. Pregabalin versus naltrexone in alcohol dependence: a randomised, double-blind, comparison trial.
Martinotti G; Di Nicola M; Tedeschi D; Andreoli S; Reina D; Pomponi M; Mazza M; Romanelli R; Moroni N; De Filippis R; Di Giannantonio M; Pozzi G; Bria P; Janiri L
J Psychopharmacol; 2010 Sep; 24(9):1367-74. PubMed ID: 19346279
[TBL] [Abstract][Full Text] [Related]
6. Gabapentin versus chlordiazepoxide for outpatient alcohol detoxification treatment.
Stock CJ; Carpenter L; Ying J; Greene T
Ann Pharmacother; 2013; 47(7-8):961-9. PubMed ID: 23780805
[TBL] [Abstract][Full Text] [Related]
7. Aripiprazole in the treatment of patients with alcohol dependence: a double-blind, comparison trial vs. naltrexone.
Martinotti G; Di Nicola M; Di Giannantonio M; Janiri L
J Psychopharmacol; 2009 Mar; 23(2):123-9. PubMed ID: 18515460
[TBL] [Abstract][Full Text] [Related]
8. Lack of efficacy of dextromethorphan in managing alcohol withdrawal: a preliminary report of a randomized, double-blind, placebo-controlled trial.
Huang MC; Chen CH; Pan CH; Lin SK
J Clin Psychopharmacol; 2014 Feb; 34(1):149-52. PubMed ID: 24346753
[TBL] [Abstract][Full Text] [Related]
9. Quetiapine decreases alcohol consumption, craving, and psychiatric symptoms in dually diagnosed alcoholics.
Martinotti G; Andreoli S; Di Nicola M; Di Giannantonio M; Sarchiapone M; Janiri L
Hum Psychopharmacol; 2008 Jul; 23(5):417-24. PubMed ID: 18425995
[TBL] [Abstract][Full Text] [Related]
10. Pregabalin for alcohol dependence: a critical review of the literature.
Guglielmo R; Martinotti G; Clerici M; Janiri L
Adv Ther; 2012 Nov; 29(11):947-57. PubMed ID: 23132700
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of outpatient alcohol detoxification with a combination of tiapride/carbamazepine: additional evidence.
Soyka M; Schmidt F; Schmidt P
Pharmacopsychiatry; 2006 Jan; 39(1):30-4. PubMed ID: 16453252
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of levetiracetam for outpatient alcohol detoxification.
Müller CA; Schäfer M; Schneider S; Heimann HM; Hinzpeter A; Volkmar K; Förg A; Heinz A; Hein J
Pharmacopsychiatry; 2010 Jul; 43(5):184-9. PubMed ID: 20503149
[TBL] [Abstract][Full Text] [Related]
13. Effects of pregabalin on subjective sleep disturbance symptoms during withdrawal from long-term benzodiazepine use.
Rubio G; Bobes J; Cervera G; Terán A; Pérez M; López-Gómez V; Rejas J
Eur Addict Res; 2011; 17(5):262-70. PubMed ID: 21701173
[TBL] [Abstract][Full Text] [Related]
14. Outpatient alcohol detoxification: implementation efficacy and outcome effectiveness of a model project.
Soyka M; Horak M
Eur Addict Res; 2004; 10(4):180-7. PubMed ID: 15367820
[TBL] [Abstract][Full Text] [Related]
15. High and low dosage oxcarbazepine versus naltrexone for the prevention of relapse in alcohol-dependent patients.
Martinotti G; Di Nicola M; Romanelli R; Andreoli S; Pozzi G; Moroni N; Janiri L
Hum Psychopharmacol; 2007 Apr; 22(3):149-56. PubMed ID: 17397097
[TBL] [Abstract][Full Text] [Related]
16. Multidimensionality of the Alcohol Withdrawal Symptom Checklist: a factor analysis of the Alcohol Withdrawal Symptom Checklist and CIWA-Ar.
Pittman B; Gueorguieva R; Krupitsky E; Rudenko AA; Flannery BA; Krystal JH
Alcohol Clin Exp Res; 2007 Apr; 31(4):612-8. PubMed ID: 17374040
[TBL] [Abstract][Full Text] [Related]
17. Utilizing CIWA-Ar to assess use of benzodiazepines in patients vulnerable to alcohol withdrawal syndrome.
Nuss MA; Elnicki DM; Dunsworth TS; Makela EH
W V Med J; 2004; 100(1):21-5. PubMed ID: 15119493
[TBL] [Abstract][Full Text] [Related]
18. Alcohol withdrawal syndrome: symptom-triggered versus fixed-schedule treatment in an outpatient setting.
Elholm B; Larsen K; Hornnes N; Zierau F; Becker U
Alcohol Alcohol; 2011; 46(3):318-23. PubMed ID: 21414950
[TBL] [Abstract][Full Text] [Related]
19. A combination of carbamazepine/tiapride in outpatient alcohol detoxification. Results from an open clinical study.
Soyka M; Morhart-Klute V; Horak M
Eur Arch Psychiatry Clin Neurosci; 2002 Oct; 252(5):197-200. PubMed ID: 12451459
[TBL] [Abstract][Full Text] [Related]
20. [Pregabalin for the reduction of opiate withdrawal symptoms].
Kämmerer N; Lemenager T; Grosshans M; Kiefer F; Hermann D
Psychiatr Prax; 2012 Oct; 39(7):351-2. PubMed ID: 22689280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
